Literature DB >> 23810816

A new enzyme-linked immunosorbent assay system for human hepatic triglyceride lipase.

Kazuya Miyashita1, Junji Kobayashi, Shigeyuki Imamura, Noriaki Kinoshita, Kimber L Stanhope, Peter J Havel, Katsuyuki Nakajima, Tetsuo Machida, Hiroyuki Sumino, Makoto Nara, Masami Murakami.   

Abstract

BACKGROUND: The objective of this study was to establish a new sandwich based enzyme linked immunosorbent assay (ELISA) for measuring the protein mass of human hepatic triacylglyceride lipase (HTGL).
METHOD: Two mouse monoclonal antibodies raised against human HTGL were used for the sandwich ELISA. The post-heparin plasma (PHP) samples obtained at a heparin dose of 50 unit/kg from 124 normolipidemic subjects were used for this ELISA.
RESULTS: The dynamic assay range of the developed ELISA for the HTGL was from 0.47 to 30 ng/ml. The CV was <7% in both intra- and inter-assays, and it did not cross-react with lipoprotein lipase or endothelial lipase (EL). The HTGL concentration in PHP showed a strong correlation with HTGL activity [n=121, r=0.778, p<0.001]. There was a weak relation of HTGL concentration against high-density lipoprotein cholesterol (HDL-C) [n=123, r=-0.229, p=0.011] but no relations against total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), triglycerides (TG), small dense LDL, remnant like particles cholesterol (RLP-C) and RLP-TG were confirmed. Interestingly, a weak but positive correlation between HTGL concentration and EL concentration was shown [n=122, p=0.013, r=0.224].
CONCLUSION: These results indicate that this new sandwich ELISA for measuring HTGL concentration in PHP can be applied in a daily clinical practice.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ELISA; Endothelial lipase; Hepatic triglyceride lipase

Mesh:

Substances:

Year:  2013        PMID: 23810816     DOI: 10.1016/j.cca.2013.06.016

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  2 in total

1.  GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia.

Authors:  Xuchen Hu; Geesje M Dallinga-Thie; G Kees Hovingh; Sandy Y Chang; Norma P Sandoval; Tiffany Ly P Dang; Isamu Fukamachi; Kazuya Miyashita; Katsuyuki Nakajima; Masami Murakami; Loren G Fong; Michael Ploug; Stephen G Young; Anne P Beigneux
Journal:  J Clin Lipidol       Date:  2017-06-13       Impact factor: 4.766

2.  A new enzyme-linked immunosorbent assay system for human serum hepatic triglyceride lipase.

Authors:  Kazuya Miyashita; Katsuyuki Nakajima; Isamu Fukamachi; Yuji Muraba; Takafumi Koga; Yohnosuke Shimomura; Tetsuyo Machida; Masami Murakami; Junji Kobayashi
Journal:  J Lipid Res       Date:  2017-06-20       Impact factor: 5.922

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.